Clinical Trials Sponsored by Lingyun Sun

Total 11976 results

Sun Yat-sen University

Recruiting

Shenzhen Birth Cohort Study

Pregnancy Complications | Obstetric Labor Complications | Childhood Obesity | Neurodevelopmental Disorders | Gestational Diabetes

China
Sun Yat-sen University

Recruiting

Prospectively Randomized Control Clinical Trial of FOLFOXIRI Preoperative Chemotherapy Alone on Rectal Cancer in Local Advance Comparing to Oral Capecitabine Combined With Long-term Radiation

Rectal Cancer

China
Sun Yat-sen University

Recruiting

VRD as Induction Followed by VR Maintenance in Patients With Newly Diagnosed High Risk Multiple Myeloma

Myeloma | Newly Diagnosed | High Risk

China
Sun Yat-sen University

Recruiting

PD-1 Antibody Combined With COX Inhibitor in MSI-H/dMMR or High TMB Colorectal Cancer (PCOX)

Colorectal Cancer

China
Sun Yat-sen University

Not yet recruiting

A Prospective Observational Study About Adjuvant or Neoadjuvant Chemotherapy Related Adverse Effects in Premenopausal Breast Cancer Patients

Breast Cancer

China
Sun Yat-sen University

Recruiting

Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan Criteria

Hepatocellular Carcinoma

China
Sun Yat-sen University

Recruiting

Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable Factor

Gastric Cancer

China
Sun Yat-sen University

Recruiting

Wise Practice of Chinese Hemodialysis (WISHES)

Haemolyses and Related Conditions

China
Sun Yat-sen University

Recruiting

Super Chinese Nephrotic Syndrome Registration System (SUCCESS)

Nephrotic Syndrome

China
Sun Yat-sen University

Recruiting

IgA Nephropathy Biomarkers Evaluation Study (INTEREST) (INTEREST)

IgA Nephropathy | Glomerular Diseases

China
Sun Yat-sen University

Recruiting

A Study of Gefitinib With or Without Apatinib in Patients With Advanced Non-squamous Non-Small-Cell Lung Cancer Harboring EGFR Mutations

EGFR Tyrosine Kinase Inhibitors Plus VEGFR Inhibitors

China
Sun Yat-sen University

Recruiting

Esthetic, Clinical and Radiographic Outcomes of Immediate and Delayed Implant Placement

Jaw, Edentulous, Partially | Acquired Absence of Single Tooth

China
Sun Yat-sen University

Recruiting

A Study on β-elemene as Maintain Treatment for Newly Diagnosed Malignant Gliomas (β-elemene)

Glioblastoma | Anaplastic Oligoastrocytoma | Anaplastic Astrocytoma

China
Sun Yat-sen University

Recruiting

A Prospective Multi-center Phase III Randomized Controlled Trial (NACA)

Carcinoma，Non-Small-Cell Lung

China
Sun Yat-sen University

Recruiting

Modified BFM-95 Regimen as First-Line Chemotherapy in Adults With T- Lymphoblastic Lymphoma

Lymphoma, Lymphoblastic

China
Sun Yat-sen University

Recruiting

A Retrospective Study of EGFR-TKIs,Gefitinib, Erlotinib and Osimertinib in NSCLC Patients Treatment

Non-small Cell Lung Cancer (NSCLC) | EGFR-TKI Resistant Mutation | EGFR-TKI Sensitizing Mutation | Somatic Mutation | Germline Mutations

China
Sun Yat-sen University

Recruiting

Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma

Astrocytoma | Oligodendroglioma | Oligodendroastrocytoma

China
Sun Yat-sen University

Active, not recruiting

Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy

Stage III Non-small-cell Lung Cancer

China
Sun Yat-sen University

Completed

Metronomic Chemotherapy in a Real-world Population of Advanced Breast Cancer Patients

Breast Cancer

China
Sun Yat-sen University

Completed

The Risk Assessment Scale for Peripherally Inserted Central Venous Catheter (PICC) Related Thrombosis in Cancer Patients

Thrombosis | Catheter

China
Sun Yat-sen University

Completed

Characteristics and Tumor Staging Proposal for Primary Malignant Melanoma of the Esophagus

Primary Malignant Melanoma of the Esophagus

China
Sun Yat-sen University

Active, not recruiting

Metronomic Capecitabine Plus Aromatase Inhibitor for First Line Treatment in HR(+), Her2(-) Metastatic Breast Cancer (MECCA)

Breast Cancer

China
Sun Yat-sen University

Active, not recruiting

Toripalimab Plus Neoadjuvant Chemotherapy Combined With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma

China
Sun Yat-sen University

Completed

Atezolizumab Plus Bevacizumab Versus Sintilimab Plus Bevacizumab With TACE and HAIC in Unresectable Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Sun Yat-sen University

Completed

A Conversational AI System to Enhance Knowledge About Vaccines and Promote Vaccination

Vaccination Hesitancy

China
Sun Yat-sen University

Completed

Efficacy of Using Large Language Model to Assist in Diabetic Retinopathy Detection

Diabetic Retinopathy | Diagnosis

China
Sun Yat-sen University

Active, not recruiting

Study of Porcine Fibrin Sealant in Preventing Cervical Anastomotic Leakage (PLACE030)

Esophageal Anastomotic Leak

China
Sun Yat-sen University

Active, not recruiting

SBRT Followed by Neoadjuvant Immunochemotherapy in Resectable Stage II to III Non-small Cell Lung Cancer (SACTION01)

Carcinoma, Non-Small-Cell Lung

China
Sun Yat-sen University

Active, not recruiting

A Study of Cadonilimab Combined With Regorafenib in Patients With Advanced HCC

Advanced Hepatocellular Carcinoma

China
Sun Yat-sen University

Completed

Study of Early Nutritional Intervention During Concurrent Chemoradiotherapy for Local Advanced Non-small Cell Lung Cancer

Local Advanced Non-small Cell Lung Cancer

China
Sun Yat-sen University

Active, not recruiting

The Role of Induction Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma in the Era of IMRT

Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Enrolling by invitation

Chemotherapy Combined With High-dose Radiotherapy for Low Rectal Cancer Using MR Guided Linear Accelerator

Rectal Cancer

China
Sun Yat-sen University

Completed

Exploring the Influence of Clinical Factors on the Prognosis of Papillary Renal Cell Carcinoma

Carcinoma, Renal Cell
Sun Yat-sen University

Active, not recruiting

TNT to Increase the Clinical Complete Response Rate for Distal LARC (TESS)

Chemoradiation | Rectal Cancer | Rectal Cancer Stage II | Rectal Cancer Stage III

China
Sun Yat-sen University

Active, not recruiting

Follow-up Strategy for Esophageal Cancer Patients

Esophagus Cancer

China
Sun Yat-sen University

Completed

Bevacizumab Combined With Fractionated Stereotactic Radiotherapy for 1 to 10 Brain Metastases From NSCLC

Non-small Cell Lung Cancer

China
Sun Yat-sen University

Completed

Vitamin C Intravenously With Chemotherapy in Advanced Colorectal Cancer (Vitality)

Colorectal Neoplasms

China
Sun Yat-sen University

Active, not recruiting

Nab-paclitaxel Based TPX Neoadjuvant Chemotherapy for NPC Patients: a Dose-escalation Study

Nasopharyngeal Cancer

China
Sun Yat-sen University

Active, not recruiting

Microvascular Invasion for Guiding Treatment of Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma

Hepatocellular Carcinoma (HCC) | Radiomics | Transcatheter Arterial Chemoembolization (TACE) | Microvascular Invasion (MVI) | Multi-kinase Inhibitors (MKI)

China
Sun Yat-sen University

Completed

Tislelizumab Combined With Pemetrexed/ Carboplatin in Patients With Brain Metastases of Non-squamous NSCLC

Brain Metastases | NSCLC Stage IV | PD-1 Antibody

China
Sun Yat-sen University

Completed

High Dose Radiotherapy for the Treatment of Rectal Cancer

Rectal Cancer

China
Sun Yat-sen University

Completed

TPC vs PF as Induction Chemotherapy Combined With CCRT for Stage IVa-b Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Completed

SHR-1210 in Combination With Apatinib in Patients With Metastatic, Persistent, or Recurrent Cervical Cancer

Recurrent Cervical Carcinoma | Metastatic Cervical Cancer

China
Sun Yat-sen University

Completed

Bevacizumab After Chemoradiotherapy For Locally Advanced Lung Adenocarcinoma

Lung Adenocarcinoma

China
Sun Yat-sen University

Terminated

FUDR/Oxaliplatin HAI Plus Irinotecan vs. FOLFOXIRI Chemotherapy in Treating Initially Unresectable CRCLM

Metastatic Colorectal Cancer | Liver Metastases

China
Sun Yat-sen University

Active, not recruiting

Toripalimab and Gemcitabine in Recurrent or Metastatic Nasopharyngeal Carcinoma.

Nasopharyngeal Carcinoma | Chemotherapy Effect | Immunotherapy | Recurrent Nasopharyngeal Carcinoma | Metastatic Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Completed

Tumor Budding in Patients With Colorectal Cancer Under Different MMR Status

Rectal Cancer | Tumor Budding

China
Sun Yat-sen University

Completed

PD-1 Antibody in EBV Positive Metastatic Gastric Cancer Patients.

Gastric Cancer Stage IV | EBV

China
Sun Yat-sen University

Completed

Surgery Alone Versus Neoadjuvant Treatment Followed by Surgery For MRI-defined T3 Mid-low Rectal Cancer

Rectal Cancer
Sun Yat-sen University

Completed

TIP (Paclitaxel + Ifosfamide + Cisplatin) Combined With Nimotuzumab & Triprilimab as Neoadjuvant Treatment in Locally Advanced Penile Cancer

Penile Cancer

China

3

Subscribe